Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
Figlin, R A
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success? [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology 02 2018 - 324-331 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1569-8041
10.1093/annonc/mdx743 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant--methods
Disease-Free Survival
Humans
Kidney Neoplasms--drug therapy
Molecular Targeted Therapy--methods
Neoplasm Recurrence, Local--pathology
Patient Selection
Risk Factors
Treatment Outcome
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success? [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology 02 2018 - 324-331 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1569-8041
10.1093/annonc/mdx743 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant--methods
Disease-Free Survival
Humans
Kidney Neoplasms--drug therapy
Molecular Targeted Therapy--methods
Neoplasm Recurrence, Local--pathology
Patient Selection
Risk Factors
Treatment Outcome